lisinopril

Generic: lisinopril

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lisinopril
Generic Name lisinopril
Labeler aphena pharma solutions - tennessee, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

lisinopril 2.5 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-741
Product ID 71610-741_9f5db76f-349d-4856-b7d9-ded1ab8ca656
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075743
Listing Expiration 2026-12-31
Marketing Start 2017-08-30

Pharmacologic Class

Classes
angiotensin converting enzyme inhibitor [epc] angiotensin-converting enzyme inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610741
Hyphenated Format 71610-741

Supplemental Identifiers

RxCUI
311353
UNII
E7199S1YWR

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lisinopril (source: ndc)
Generic Name lisinopril (source: ndc)
Application Number ANDA075743 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (71610-741-30)
  • 45 TABLET in 1 BOTTLE (71610-741-45)
  • 60 TABLET in 1 BOTTLE (71610-741-53)
  • 90 TABLET in 1 BOTTLE (71610-741-60)
  • 120 TABLET in 1 BOTTLE (71610-741-70)
  • 150 TABLET in 1 BOTTLE (71610-741-75)
  • 180 TABLET in 1 BOTTLE (71610-741-80)
source: ndc

Packages (7)

71610-741-30 30 TABLET in 1 BOTTLE (71610-741-30) 71610-741-45 45 TABLET in 1 BOTTLE (71610-741-45) 71610-741-53 60 TABLET in 1 BOTTLE (71610-741-53) 71610-741-60 90 TABLET in 1 BOTTLE (71610-741-60) 71610-741-70 120 TABLET in 1 BOTTLE (71610-741-70) 71610-741-75 150 TABLET in 1 BOTTLE (71610-741-75) 71610-741-80 180 TABLET in 1 BOTTLE (71610-741-80)

Ingredients (1)

lisinopril (2.5 mg/1)

Linked Drug Pages (1)

Lisinopril ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "9f5db76f-349d-4856-b7d9-ded1ab8ca656", "openfda": {"unii": ["E7199S1YWR"], "rxcui": ["311353"], "spl_set_id": ["a79a034d-7bbb-4b05-b8fc-8ebf09f33c0c"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (71610-741-30)", "package_ndc": "71610-741-30", "marketing_start_date": "20231003"}, {"sample": false, "description": "45 TABLET in 1 BOTTLE (71610-741-45)", "package_ndc": "71610-741-45", "marketing_start_date": "20231003"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (71610-741-53)", "package_ndc": "71610-741-53", "marketing_start_date": "20231003"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-741-60)", "package_ndc": "71610-741-60", "marketing_start_date": "20231003"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (71610-741-70)", "package_ndc": "71610-741-70", "marketing_start_date": "20231003"}, {"sample": false, "description": "150 TABLET in 1 BOTTLE (71610-741-75)", "package_ndc": "71610-741-75", "marketing_start_date": "20231003"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE (71610-741-80)", "package_ndc": "71610-741-80", "marketing_start_date": "20231003"}], "brand_name": "Lisinopril", "product_id": "71610-741_9f5db76f-349d-4856-b7d9-ded1ab8ca656", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]"], "product_ndc": "71610-741", "generic_name": "Lisinopril", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisinopril", "active_ingredients": [{"name": "LISINOPRIL", "strength": "2.5 mg/1"}], "application_number": "ANDA075743", "marketing_category": "ANDA", "marketing_start_date": "20170830", "listing_expiration_date": "20261231"}